Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!


Recent Discussions

  • Posted in: IDea Exchange

    Colleagues,  Curious what others--and notably our ID pharmacists--are advising high risk COVID-19 patients who are nirmatrelvir/ritonavir candidates but on apixaban or rivaroxaban for DVT/PE or Atrial Fibrillation indication.  Let's assume no access to ...

  • Posted in: IDea Exchange

    The AHRQ also has a nice ressource on this: https://www.ahrq.gov/antibiotic-use/acute-care/safety/communication.html ------------------------------ Elie Saade MD;MPH Physician University Hospitals Cleveland Medical Center Cleveland OH --------- ...

  • The   Grants for Emerging Researchers/Clinicians Mentorship Program   is recruiting medical students with interest in career paths in ID and HIV to apply for the program. Awardees will receive a $4,000 stipend to complete their project and be paired ...

New Guidelines Update

Treatment and Management of Patients with COVID-19 Guideline 

Given the rapidity of emerging literature, the Infectious Diseases Society of America (IDSA) identified the need to develop living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID

Read More

COVID-19 Real-Time Learning Network

The COVID-19 Real-Time Learning Network is a curated repository of clinical guidance, emerging research, and practice management tools to support clinicians of all backgrounds. With funding from the Centers for Disease Control and Prevention and guidance from a multidisciplinary Advisory Group, this site is updated daily with must-have information for clinicians and decision-makers.

Read More


Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Help attract the best and brightest to the field of infectious diseases.

IDSA Foundation